NCT05135065

Brief Summary

This project proposes to reduce disparities in care among disadvantaged racial/ethnic minority adolescents with ADHD by improving community therapist fidelity to evidence-based behavior therapy through a technology-assisted supervision intervention. In Y01, the research team will work with stakeholders to develop the proposed supervision intervention utilizing two novel technologies: Lyssn + Care4 (LC4S). In Y02, a preliminary clinical trial (N=72) will be conducted in three community mental health agencies in Miami, FL. Adolescent participants will be randomly assigned to receive supervision from a therapist who is trained in LCS4 or provides enhanced supervision as usual(ESAU)using a permuted block randomization strategy that randomizes within site. There will also be double randomization of agency therapists to supervisors. Supervisors will deliver both conditions and investigators will test for contamination to determine the integrity of this design prior to a future R01 that measures patient outcomes. Data from therapists, adolescents and their parents, and supervisors will be collected pre-training, post-training, weekly during service delivery, at EBT completion, and at the end of the trial. The proximal intervention target is therapist fidelity to EBT and the distal targets are service delivery outcomes that include quality, quantity, and speed of delivery. Investigators will also measure indices of consumer fit: cost, acceptability, feasibility, and fidelity to supervision procedures. Sources of data will be audio recorded therapy and supervision sessions, therapist and supervisor report, and project and electronic health records. In longitudinal analyses, time will be modeled as a person-specific variable representing months since baseline. Investigators will nest adolescents within therapists for all analyses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 24, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

November 18, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 26, 2021

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

April 24, 2026

Status Verified

April 1, 2026

Enrollment Period

2.8 years

First QC Date

September 24, 2021

Last Update Submit

April 21, 2026

Conditions

Keywords

ADHDAdolescentsCommunity Mental Health

Outcome Measures

Primary Outcomes (2)

  • Therapist STAND Fidelity

    Behavior therapy content: STAND treatment fidelity checklists (Sibley et al., 2013, 2016, 2019). This data will be collected via therapist self-report, Lyssn (the machine learning tool), and coded by trained research assistants from audio recordings. If there is a discrepancy in sources, a trained RA will code the tape to resolve the discrepancy.

    Weekly for an average of 9 months

  • Therapist MITI Fidelity

    Behavior therapy content:Motivational Interviewing Treatment Integrity (MITI) measure (Moyers et al., 2014) will measure MI integrity.This data will be collected via therapist self-report, Lyssn (the machine learning tool), and coded by trained research assistants from audio recordings. If there is a discrepancy in sources, a trained RA will code the tape to resolve the discrepancy.

    Weekly for an average of 9 months

Secondary Outcomes (2)

  • Service Delivery Quality

    Weekly for duration that case is active in the agency, an average of 9 months

  • Service Delivery Quantity

    Weekly for duration that case is active in the agency, an average of 9 months

Other Outcomes (7)

  • Cost

    cost will be computed at the end of the year from study records and electronic heath records, an average of 9 months

  • Technology Acceptability

    At end of the study, after an average of 9 months

  • Satisfaction with supervision

    At end of the study, after an average of 9 months

  • +4 more other outcomes

Study Arms (2)

Artificial Intelligence-Assisted Supervision Protocol

EXPERIMENTAL

Measurement-based supervision protocol that incorporates fidelity measurement from a machine learning tool and feedback reports from this tool into a standardized supervision protocol for behavior therapy to task-shift burdensome supervision tasks to a machine, reducing costs and improving precision of fidelity measurement for agencies.

Other: Artificial Intelligence-Assisted Supervision Protocol

Enhanced Supervision as Usual (ESAU) Condition

NO INTERVENTION

ESAU therapists will be given standard, paper-based facilitation resources for STAND and will receive 4 hours of training on how to navigate these materials and self-assess fidelity. ESAU therapists will also be trained how to upload recordings into Care4 and complete self-assessments for each session. Supervisors will be given access to these data and recordings once uploaded (but not Lyssn scores or electronic facilitation resources).

Interventions

Measurement-based supervision protocol that incorporates fidelity measurement from a machine learning tool and feedback reports from this tool into a standardized supervision protocol for behavior therapy to task-shift burdensome supervision tasks to a machine, reducing costs and improving precision of fidelity measurement for agencies.

Artificial Intelligence-Assisted Supervision Protocol

Eligibility Criteria

Age11 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • DSM-5 ADHD diagnosis, Enrollment in 6th-12th grade, IQ greater than 70, no history of autism spectrum disorder or thought disorder, client of one of two community mental health agencies

You may not qualify if:

  • Autism Spectrum/Thought Disorders, IQ\<70

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seattle Children's Research Institute

Seattle, Washington, 98145, United States

Location

Related Publications (1)

  • Sibley MH, Bickman L, Atkins D, Coxe S, King J, Tanana M, Martin P, Page TF, Ortiz M, Tapia J, Sparber A, Zhao X. Improving Community-Based Care for Adolescents with ADHD: a Randomized Controlled Trial of Artificial Intelligence-Assisted Fidelity Supports. Prev Sci. 2025 Dec 24. doi: 10.1007/s11121-025-01868-x. Online ahead of print.

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Study Officials

  • Margaret H Sibley, Ph.D

    Seattle Children's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 24, 2021

First Posted

November 26, 2021

Study Start

November 18, 2021

Primary Completion

August 30, 2024

Study Completion

December 1, 2024

Last Updated

April 24, 2026

Record last verified: 2026-04

Locations